LPCN stock news
This page provides real-time market news, earnings updates, and company announcements related to Lipocine Inc. (LPCN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-08 09:35 EST
Lipocine (LPCN) Jumps 5.5%: Does the Stock Have More Room to Grow?
101 finance2026-02-27 13:48:39
Lipocine: Fourth Quarter Financial Results Overview
101 finance2026-03-10 10:31:08
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
Finviz2026-04-02 12:03:39
Lipocine Inc (ticker: LPCN) announced that its experimental drug for postpartum depression failed to meet the primary endpoint in its Phase III clinical trial, causing the company's stock price to plummet by 78.4% in pre-market trading.
老虎证券2026-04-02 13:16:26
LPCN stock chart
LPCN stock detailsLPCN stock price change
On the last trading day, LPCN stock closed at 1.94 USD, with a price change of -5.37% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more